These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21790611)

  • 1. Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.
    Jackson RL; Greiwe JS; Schwen RJ
    Nutr Rev; 2011 Aug; 69(8):432-48. PubMed ID: 21790611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor β-agonist being developed for the treatment of menopausal symptoms.
    Jackson RL; Greiwe JS; Desai PB; Schwen RJ
    Menopause; 2011 Feb; 18(2):185-93. PubMed ID: 21341397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
    McCarty MF
    Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is equol production beneficial to health?
    Magee PJ
    Proc Nutr Soc; 2011 Feb; 70(1):10-8. PubMed ID: 21092366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
    Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.
    Frankenfeld CL; McTiernan A; Thomas WK; LaCroix K; McVarish L; Holt VL; Schwartz SM; Lampe JW
    Maturitas; 2006 Feb; 53(3):315-24. PubMed ID: 16019168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.
    Hazim S; Curtis PJ; Schär MY; Ostertag LM; Kay CD; Minihane AM; Cassidy A
    Am J Clin Nutr; 2016 Mar; 103(3):694-702. PubMed ID: 26843154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research development on relation between equol and soy foods health effect].
    Liu B; Qin L; Wang P
    Wei Sheng Yan Jiu; 2010 Nov; 39(6):784-6. PubMed ID: 21351654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.
    Yuan JP; Wang JH; Liu X
    Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimentally induced mastitis and metritis modulate soy bean derived isoflavone biotransformation in diary cows.
    Kowalczyk-Zieba I; Woclawek-Potocka I; Piskula MK; Piotrowska-Tomala KK; Boruszewska D; Bah MM; Siemieniuch MJ; Skarzynski DJ
    Theriogenology; 2011 Dec; 76(9):1744-55. PubMed ID: 21890188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.
    Setchell KD; Clerici C; Lephart ED; Cole SJ; Heenan C; Castellani D; Wolfe BE; Nechemias-Zimmer L; Brown NM; Lund TD; Handa RJ; Heubi JE
    Am J Clin Nutr; 2005 May; 81(5):1072-9. PubMed ID: 15883431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia.
    Sekikawa A; Wharton W; Butts B; Veliky CV; Garfein J; Li J; Goon S; Fort A; Li M; Hughes TM
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro.
    Magee PJ; Raschke M; Steiner C; Duffin JG; Pool-Zobel BL; Jokela T; Wahala K; Rowland IR
    Nutr Cancer; 2006; 54(2):232-42. PubMed ID: 16898868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
    Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bugel S; Reimann M; Koebnick C; Zunft HJ; Ferrari M; Branca F; Dadd T; Talbot D; Powell J; Minihane AM; Cassidy A; Nilsson M; Dahlman-Wright K; Gustafsson JA; Williams CM
    Am J Clin Nutr; 2006 Mar; 83(3):592-600. PubMed ID: 16522905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
    Raschke M; Wähälä K; Pool-Zobel BL
    Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice.
    Selvaraj V; Zakroczymski MA; Naaz A; Mukai M; Ju YH; Doerge DR; Katzenellenbogen JA; Helferich WG; Cooke PS
    Biol Reprod; 2004 Sep; 71(3):966-72. PubMed ID: 15151933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans.
    Wiseman H; O'Reilly JD; Adlercreutz H; Mallet AI; Bowey EA; Rowland IR; Sanders TA
    Am J Clin Nutr; 2000 Aug; 72(2):395-400. PubMed ID: 10919933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
    Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
    Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.